表紙
市場調查報告書

末稍血管用設備的歐洲市場:2020年∼2026年

Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite

出版商 iData Research Inc. 商品編碼 937772
出版日期 內容資訊 英文 914 Pages
商品交期: 最快1-2個工作天內
價格
末稍血管用設備的歐洲市場:2020年∼2026年 Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite
出版日期: 2020年04月28日內容資訊: 英文 914 Pages
簡介

歐洲的末稍血管用設備市場在2019年估算為約13億歐元,到2026年達到約16億歐元,在預測期間內預計將以年複合成長率2.9%成長。

本報告提供歐洲的末稍血管用設備市場相關調查分析,提供市場分析 (銷售數量,ASP,市場金額·成長率趨勢) 、推動市場要素與阻礙要素,競爭分析,最近的M&A等相關的系統性資訊。

目錄

圖的清單

表(圖表)的清單

摘要整理

末稍血管用設備的歐洲市場概要

競爭分析

市場趨勢

市場發展

治療數量

對象市場

版本履歷

調查手法

疾病概要

  • 基本結構
  • 病的治療和診斷
  • 患者的人口統計

產品系列

  • 簡介
  • 產品系列
  • 法規問題和回收
  • 臨床試驗

末稍血管用設備市場概要

  • 簡介
    • 動脈粥狀硬化性心血管疾病
    • 週邊動脈疾病(PAD)
  • 匯率
  • 市場概要
  • 趨勢分析
  • 促進因素·阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析
  • 企業簡介
  • SWOT分析
  • M&A

國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

治療數量

  • 治療

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_EUPV20_MS

The European peripheral vascular device market was valued at about €1.3 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.9% to reach about €1.6 billion by 2026.

The growth of venous treatments in Europe is expected to accelerate in the coming years as clinical knowledge continues to develop and expertise in the medical community is diffused. While currently consolidated within select regions in the United Kingdom, Germany, France, Austria and Switzerland, venous treatment centers are expected to be developed across Europe to facilitate both the diagnosis and treatment of venous disease.

Treatment of peripheral arterial disease is slowly continuing to increase its penetration in the treatable population. As Europe continues to age, the total number of procedures is expected to

grow over the forecast period. As reimbursement tensions continue, treatment techniques have continued to be refined towards the most cost effective, long-term option for patients.

The full report suite on the European market for peripheral vascular (PV) devices includes peripheral arterial stents, peripheral venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. There is also a series of appendices containing analyses on drug-coated balloons (DCBs), lithotripsy balloon catheters and peripheral intravascular ultrasound (IVUS) catheters.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR PERIPHERAL VASCULAR DEVICES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 BASIC ANATOMY
  • 2.2 DISEASE TREATMENTS & DIAGNOSTICS
    • 2.2.1 Aortic Aneurysms
    • 2.2.2 Atherosclerosis
    • 2.2.3 Peripheral Arterial Disease (PAD)
    • 2.2.4 Deep Vein Thrombosis (DVT)
    • 2.2.5 Pulmonary Embolism (PE)
  • 2.3 PATIENT DEMOGRAPHICS
    • 2.3.1 Aortic Aneurysms
    • 2.3.2 Atherosclerosis
    • 2.3.3 Peripheral Arterial Disease (PAD)
    • 2.3.4 Deep Vein Thrombosis (DVT)
    • 2.3.5 Pulmonary Embolism (PE)

PRODUCT PORTFOLIO

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS
    • 3.2.1 Peripheral Vascular Stent
    • 3.2.2 Venous Stent
    • 3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon
    • 3.2.4 Drug-Coated Balloon
    • 3.2.5 Atherectomy Device
    • 3.2.6 Chronic Total Occlusion (CTO) Device
    • 3.2.7 Intravascular Lithotripsy
    • 3.2.8 Surgical Graft
    • 3.2.9 Stent Graft
    • 3.2.10 Embolic Protection Device
    • 3.2.11 Peripheral Thrombus Management Device
    • 3.2.12 Inferior Vena Cava Filter
    • 3.2.13 Carotid Shunt
    • 3.2.14 Diagnostic and Interventional Catheters
    • 3.2.15 Diagnostic and Interventional Guidewire
    • 3.2.16 Introducer Sheath
    • 3.2.17 Vascular Closure Device (VCD)
    • 3.2.18 Transcatheter Embolization Device
    • 3.2.19 Peripheral IVUS Catheter
  • 3.3 REGULATORY ISSUES AND RECALLS
    • 3.3.1 Abbott
      • 3.3.1.1 Carotid Shunt
      • 3.3.1.2 Vascular Closure Device
    • 3.3.2 Argon Medical
      • 3.3.2.1 Introducer Sheaths
    • 3.3.3 Arrow International
      • 3.3.3.1 Introducer Sheaths
    • 3.3.4 Atrium Medical
      • 3.3.4.1 Peripheral Vascular Stent
    • 3.3.5 BD
      • 3.3.5.1 Inferior Vena Cava Filter
      • 3.3.5.2 Introducer Sheaths
      • 3.3.5.3 Stent Graft
    • 3.3.6 Boston Scientific
      • 3.3.6.1 Atherectomy Devices
      • 3.3.6.2 Diagnostic and Interventional Catheters
      • 3.3.6.3 Introducer Sheaths
      • 3.3.6.4 Peripheral Thrombus Management Devices
    • 3.3.7 Cardinal Health
      • 3.3.7.1 Vascular Closure Devices
    • 3.3.8 Cardiovascular System (C.S.I.)
      • 3.3.8.1 Atherectomy Devices
    • 3.3.9 Cook Medical
      • 3.3.9.1 Diagnostic and Interventional Catheters
      • 3.3.9.2 Introducer Sheaths
      • 3.3.9.3 Inferior Vena Cava Filters
      • 3.3.9.4 Peripheral Vascular Stents
      • 3.3.9.5 Stent Grafts
    • 3.3.10 Cordis (Cardinal Health)
      • 3.3.10.1 Diagnostic and Interventional Catheters
      • 3.3.10.2 Inferior Vena Cava Filters
      • 3.3.10.3 Peripheral Stents
    • 3.3.11 Endologix
      • 3.3.11.1 Stent Grafts
    • 3.3.12 Edwards Lifesciences
      • 3.3.12.1 Chronic Total Occlusion Devices
    • 3.3.13 Maquet
      • 3.3.13.1 PTA Balloons
    • 3.3.14 Medtronic
      • 3.3.14.1 Carotid Shunts
      • 3.3.14.2 Diagnostic and Interventional Catheters
      • 3.3.14.3 PTA Balloon Catheters
      • 3.3.14.4 Peripheral Stents
      • 3.3.14.5 Stent Grafts
      • 3.3.14.6 Transcatheter Embolization Devices
    • 3.3.15 Spectranetics (Philips)
      • 3.3.15.1 Atherectomy Devices
      • 3.3.15.2 Chronic Total Occlusion Devices
    • 3.3.16 Shockwave Medical, Inc.
      • 3.3.16.1 Intravascular Lithotripsy
    • 3.3.17 Terumo
      • 3.3.17.1 Introducer Sheaths
      • 3.3.17.2 PTA Balloon Catheters
    • 3.3.18 Other Companies
      • 3.3.18.1 Atherectomy Devices
      • 3.3.18.2 Introducer Sheaths
      • 3.3.18.3 PTA Balloon Catheters
      • 3.3.18.4 Peripheral IVUS Catheters
      • 3.3.18.5 Stent Grafts
      • 3.3.18.6 Vascular Closure Devices (VCD)
  • 3.4 CLINICAL TRIALS
    • 3.4.1 Abbott
      • 3.4.1.1 Peripheral Vascular Stent
      • 3.4.1.2 Other Peripheral Vascular Related Studies
    • 3.4.2 B. Braun
      • 3.4.2.1 Diagnostic and Interventional Catheters
      • 3.4.2.2 Peripheral Vascular Stent
    • 3.4.3 Boston Scientific
      • 3.4.3.1 Atherectomy Devices
      • 3.4.3.2 Drug-Coated Balloons
      • 3.4.3.3 Peripheral Vascular Stents
      • 3.4.3.4 Other Peripheral Vascular Related Studies
      • 3.4.3.5 Venous Stents
    • 3.4.4 C.R. Bard (BD)
      • 3.4.4.1 Diagnostic and Interventional Catheters
      • 3.4.4.2 Drug-Coated Balloons
      • 3.4.4.3 Venous Stents
      • 3.4.4.4 Other Peripheral Vascular Related Studies
    • 3.4.5 Cardinal Health
      • 3.4.5.1 Other Peripheral Vascular Related Studies
    • 3.4.6 Cook Medical
      • 3.4.6.1 Drug-Eluting Stents
      • 3.4.6.2 Inferior Vena Cava Filters
      • 3.4.6.3 Peripheral Vascular Stents
      • 3.4.6.4 Venous Stents
    • 3.4.7 Cordis (Cardinal Health)
      • 3.4.7.1 Peripheral Vascular Stents
    • 3.4.8 Medtronic
      • 3.4.8.1 Atherectomy Devices
      • 3.4.8.2 Drug-Coated Balloons
      • 3.4.8.3 Other Peripheral Vascular Related Studies
    • 3.4.9 Merit Medical
      • 3.4.9.1 Stent Grafts
    • 3.4.10 Philips/Spectranetics
      • 3.4.10.1 Atherectomy Devices
      • 3.4.10.2 Peripheral IVUS Catheters
      • 3.4.10.3 Spectranetics
      • 3.4.10.3.1 Drug-Coated Balloons
      • 3.4.10.3.2 Atherectomy Devices
    • 3.4.11 Shockwave Medical, Inc.
      • 3.4.11.1 Lithoplasty System
    • 3.4.12 Surmodics
      • 3.4.12.1 Drug-Coated Balloons
    • 3.4.13 Terumo
      • 3.4.13.1 Drug-Coated Balloons
      • 3.4.13.2 Peripheral Vascular Stents
    • 3.4.14 W.L. Gore
      • 3.4.14.1 Peripheral Vascular Stents
      • 3.4.14.2 Stent Grafts
      • 3.4.14.3 Expandable Balloons
    • 3.4.15 Other Companies
      • 3.4.15.1 Carotid Shunt / Endarterectomy
      • 3.4.15.2 Drug-Coated Balloons
      • 3.4.15.3 Peripheral Vascular Stents
      • 3.4.15.4 Other Peripheral Vascular Related Studies

PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

  • 4.1 INTRODUCTION
    • 4.1.1 Atherosclerosis
    • 4.1.2 Peripheral Arterial Disease (PAD)
  • 4.2 CURRENCY EXCHANGE RATE
  • 4.3 MARKET OVERVIEW
  • 4.4 TREND ANALYSIS
  • 4.5 DRIVERS AND LIMITERS
    • 4.5.1 Market Drivers
    • 4.5.2 Market Limiters
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS
  • 4.7 COMPANY PROFILES
    • 4.7.1 Abbott
    • 4.7.2 Becton Dickinson (BD)
    • 4.7.3 Boston Scientific
    • 4.7.4 Cardinal Health
      • 4.7.4.1 Cordis (Cardinal Health)
    • 4.7.5 Cook Medical
    • 4.7.6 Maquet
    • 4.7.7 Medtronic
    • 4.7.8 Teleflex
    • 4.7.9 Terumo Interventional System (TIS)
    • 4.7.10 W.L. Gore
  • 4.8 SWOT ANALYSIS
    • 4.8.1 Abbott
    • 4.8.2 B. Braun
    • 4.8.3 Boston Scientific
    • 4.8.4 BD
    • 4.8.5 Cardinal Health
    • 4.8.6 Cook Medical
    • 4.8.7 Integra Lifesciences
    • 4.8.8 Maquet
    • 4.8.9 Medtronic
    • 4.8.10 Merit Medical
    • 4.8.11 Phillips
    • 4.8.12 Teleflex
    • 4.8.13 Terumo
    • 4.8.14 W.L. Gore
  • 4.9 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 5.1 INTRODUCTION
      • 5.1.1.1 Population
      • 5.1.1.2 Median Age
      • 5.1.1.3 GDP Per Capita
      • 5.1.1.4 Price Index
  • 5.2 GERMANY
  • 5.3 FRANCE
  • 5.4 UNITED KINGDOM
  • 5.5 ITALY
  • 5.6 SPAIN
  • 5.7 BENELUX
  • 5.8 SCANDINAVIA
  • 5.9 AUSTRIA
  • 5.10 SWITZERLAND
  • 5.11 PORTUGAL

PROCEDURE NUMBERS

  • 6.1 PROCEDURES
    • 6.1.1 Total Procedures
    • 6.1.2 Bare Metal Stent Procedures
      • 6.1.2.1 Iliac Bare Metal Stent Procedures
      • 6.1.2.2 Femoral Popliteal Bare Metal Stent Procedures
      • 6.1.2.3 Infra-Popliteal Bare Metal Stent Procedures
      • 6.1.2.4 Renal Bare Metal Stent Procedures
      • 6.1.2.5 Carotid Bare Metal Stent Procedures
    • 6.1.3 Venous Stenting Procedures
    • 6.1.4 Angioplasty Procedures
    • 6.1.5 Atherectomy Procedures
    • 6.1.6 Chronic Total Occlusion Procedures
    • 6.1.7 Embolic Protection Device Procedures
    • 6.1.8 Stent Graft Procedures
      • 6.1.8.1 AAA Stent Graft Procedures
      • 6.1.8.2 TAA Stent Graft Procedures
      • 6.1.8.3 Fenestrated Stent Graft Procedures
    • 6.1.9 Surgical Graft Procedures
      • 6.1.9.1 Lower Limb Surgical Graft Procedures
      • 6.1.9.2 AV Access Surgical Graft Procedures
      • 6.1.9.3 Aorta Repair Surgical Graft Procedures
      • 6.1.9.3.1 AAA Surgical Graft Procedures
      • 6.1.9.3.2 TAA Surgical Graft Procedures
      • 6.1.9.4 Extra-Anatomical Surgical Graft Procedures
    • 6.1.10 AV Access Thrombectomy Procedures
    • 6.1.11 Inferior Vena Cava Filter Procedures
    • 6.1.12 Vascular Closure Device Procedures
      • 6.1.12.1 Total Invasive Vascular Closure Device Procedures
      • 6.1.12.1.1 Invasive Small Bore Vascular Closure Device Procedures
      • 6.1.12.1.2 Invasive Large Bore Vascular Closure Device Procedures
      • 6.1.12.2 Non-Invasive Vascular Closure Device Procedures
      • 6.1.12.3 Vascular Closure Device Procedures by Approach
      • 6.1.12.3.1 Femoral Vascular Closure Device Procedures
      • 6.1.12.3.2 Radial Vascular Closure Device Procedures
    • 6.1.13 Transcatheter Embolization Procedures
      • 6.1.13.1 Particle Embolization Procedures
      • 6.1.13.2 Coil Embolization Procedures
      • 6.1.13.3 Liquid Embolization Procedures
    • 6.1.14 Drug-Coated Balloon Procedures
    • 6.1.16 Lithotripsy Procedures
    • 6.1.17 IVUS Procedures

PERIPHERAL ARTERIAL STENT MARKET

  • 7.1 INTRODUCTION
    • 7.1.1 Off-Label Use
    • 7.1.2 Covered Stents
    • 7.1.3 Drug-Eluting Stents
    • 7.1.4 Stent Length
  • 7.2 MARKET OVERVIEW
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Total Peripheral Arterial Stent Market
    • 7.3.2 Total Bare-Metal Stent Market
      • 7.3.2.1 Bare-Metal Illiac Stent Market
      • 7.3.2.2 Bare-Metal Femoral-Popliteal Stent Market
      • 7.3.2.3 Bare-Metal Infra-Popliteal Market
      • 7.3.2.4 Bare-Metal Renal Stent Market
      • 7.3.2.5 Bare-Metal Carotid Stent Market
      • 7.3.2.6 Total Bare-Metal Stent Unit Analysis by Indication
    • 7.3.3 Covered Stent Market
    • 7.3.4 Drug-Eluting Stent Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS

PERIPHERAL VENOUS STENT MARKET

  • 8.1 INTRODUCTION
  • 8.2 MARKET ANALYSIS AND FORECAST
  • 8.3 DRIVERS AND LIMITERS
    • 8.3.1 Market Drivers
    • 8.3.2 Market Limiters
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS

PTA BALLOON CATHETER MARKET

  • 9.1 INTRODUCTION
    • 9.1.1 Types of PTA Balloon Catheters
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST
    • 9.3.1 Total PTA Balloon Catheter Market
    • 9.3.2 Standard PTA Balloon Catheter Market
    • 9.3.3 High-Pressure PTA Balloon Catheter Market
    • 9.3.4 Large PTA Balloon Catheter Market
    • 9.3.5 Small PTA Balloon Catheter Market
    • 9.3.6 Specialty PTA Balloon Catheter Market
  • 9.4 DRIVERS AND LIMITERS
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS

ATHERECTOMY DEVICE MARKET

  • 10.1 INTRODUCTION
  • 10.2 MARKET ANALYSIS AND FORECAST
  • 10.3 DRIVERS AND LIMITERS
    • 10.3.1 Market Drivers
    • 10.3.2 Market Limiters
  • 10.4 COMPETITIVE MARKET SHARE ANALYSIS

CHRONIC TOTAL OCCLUSION DEVICE MARKET

  • 11.1 INTRODUCTION
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • 11.3.1 Total Chronic Total Occlusion (CTO) Device Market
    • 11.3.2 Recanalization CTO Device Market
    • 11.3.3 Re-Entry CTO Device Market
  • 11.4 DRIVERS AND LIMITERS
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS

EMBOLIC PROTECTION DEVICE MARKET

  • 12.1 INTRODUCTION
    • 12.1.1 Protection Mechanism
      • 12.1.1.1 Filter Basket
      • 12.1.1.2 Distal Balloon Occlusion
      • 12.1.1.3 Flow Redirection
  • 12.2 MARKET ANALYSIS AND FORECAST
  • 12.3 DRIVERS AND LIMITERS
    • 12.3.1 Market Drivers
    • 12.3.2 Market Limiters
  • 12.4 COMPETITIVE MARKET SHARE ANALYSIS

STENT GRAFT MARKET

  • 13.1 INTRODUCTION
  • 13.2 MARKET OVERVIEW
  • 13.3 MARKET ANALYSIS AND FORECAST
    • 13.3.1 Total Stent Graft Market
    • 13.3.2 AAA Stent Graft Market
    • 13.3.3 TAA Stent Graft Market
    • 13.3.4 Fenestrated Stent Graft
  • 13.4 DRIVERS AND LIMITERS
    • 13.4.1 Market Drivers
    • 13.4.2 Market Limiters
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS

SURGICAL GRAFT MARKET

  • 14.1 INTRODUCTION
  • 14.2 MARKET OVERVIEW
  • 14.3 MARKET ANALYSIS AND FORECAST
    • 14.3.1 Total Surgical Graft Market
    • 14.3.2 Lower Limb Surgical Graft Market
    • 14.3.3 AV Access Surgical Graft Market
    • 14.3.4 Total Aorta Repair Surgical Graft Market
      • 14.3.4.1 AAA Surgical Graft Market
      • 14.3.4.2 TAA Surgical Graft Market
    • 14.3.5 Extra-Anatomical Surgical Graft Market
  • 14.4 DRIVERS AND LIMITERS
    • 14.4.1 Market Drivers
    • 14.4.2 Market Limiters
  • 14.5 COMPETITIVE MARKET SHARE ANALYSIS

AV ACCESS THROMBECTOMY DEVICE MARKET

  • 15.1 INTRODUCTION
    • 15.1.1 Other Peripheral Applications of Thrombectomy Devices
  • 15.2 MARKET ANALYSIS AND FORECAST
  • 15.3 DRIVERS AND LIMITERS
    • 15.3.1 Market Drivers
    • 15.3.2 Market Limiters
  • 15.4 COMPETITIVE MARKET SHARE ANALYSIS

INFERIOR VENA CAVA FILTER MARKET

  • 16.1 INTRODUCTION
  • 16.2 MARKET ANALYSIS AND FORECAST
  • 16.3 DRIVERS AND LIMITERS
    • 16.3.1 Market Drivers
    • 16.3.2 Market Limiters
  • 16.4 COMPETITIVE MARKET SHARE ANALYSIS

DIAGNOSTIC AND INTERVENTIONAL CATHETER MARKET

  • 17.1 INTRODUCTION
  • 17.2 MARKET OVERVIEW
  • 17.3 MARKET ANALYSIS AND FORECAST
    • 17.3.1 Total Diagnostic and Interventional Catheter Market
    • 17.3.2 Diagnostic Catheter Market
    • 17.3.3 Interventional Catheter Market
  • 17.4 DRIVERS AND LIMITERS
    • 17.4.1 Market Drivers
    • 17.4.2 Market Limiters
  • 17.5 COMPETITIVE MARKET SHARE ANALYSIS

STANDARD AND HYDROPHILIC GUIDEWIRE MARKET

  • 18.1 INTRODUCTION
  • 18.2 MARKET OVERVIEW
  • 18.3 MARKET ANALYSIS AND FORECAST
    • 18.3.1 Total Standard and Hydrophilic Guidewire Market
    • 18.3.2 Standard Guidewire Market
    • 18.3.3 Hydrophilic Guidewire Market
  • 18.4 DRIVERS AND LIMITERS
    • 18.4.1 Market Drivers
    • 18.4.2 Market Limiters
  • 18.5 COMPETITIVE MARKET SHARE ANALYSIS

INTRODUCER SHEATH MARKET

  • 19.1 INTRODUCTION
  • 19.2 MARKET ANALYSIS AND FORECAST
  • 19.3 DRIVERS AND LIMITERS
    • 19.3.1 Market Drivers
    • 19.3.2 Market Limiters
  • 19.4 COMPETITIVE MARKET SHARE ANALYSIS

VASCULAR CLOSURE DEVICE MARKET

  • 20.1 INTRODUCTION
  • 20.2 MARKET OVERVIEW
    • 20.2.1 Vascular Closure Device Market Overview by Device Type
    • 20.2.2 Vascular Closure Device Market Overview by Approach
  • 20.3 MARKET ANALYSIS AND FORECAST
    • 20.3.1 Total Vascular Closure Device Market
    • 20.3.2 Vascular Closure Device Market by Device Type
      • 20.3.2.1 Invasive VCD Market
      • 20.3.2.1.1 Small Bore Invasive VCD Market
      • 20.3.2.1.2 Large Bore Invasive VCD Market
      • 20.3.2.2 Non-Invasive VCD Market
    • 20.3.3 Vascular Closure Device Market by Approach
      • 20.3.3.1 Femoral VCD Market
      • 20.3.3.2 Radial VCD Market
  • 20.4 DRIVERS AND LIMITERS
    • 20.4.1 Market Drivers
    • 20.4.2 Market Limiters
  • 20.5 COMPETITIVE MARKET SHARE ANALYSIS

TRANSCATHETER EMBOLIZATION DEVICE MARKET

  • 21.1 INTRODUCTION
    • 21.1.1 Particle Embolic Devices
    • 21.1.2 Coil Embolic Devices
    • 21.1.3 Liquid Embolic Devices
  • 21.2 MARKET OVERVIEW
  • 21.3 MARKET ANALYSIS AND FORECAST
    • 21.3.1 Particle Embolic Device Market
    • 21.3.2 Coil Embolic Device Market
    • 21.3.3 Liquid Embolic Device Market
  • 21.4 DRIVERS AND LIMITERS
    • 21.4.1 Market Drivers
    • 21.4.2 Market Limiters
  • 21.5 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX I: DRUG-COATED BALLOON CATHETER MARKET

  • 22.1 MARKET ANALYSIS AND FORECAST
  • 22.2 DRIVERS AND LIMITERS
    • 22.2.1 Market Drivers
    • 22.2.2 Market Limiters

APPENDIX II: INTRAVASCULAR LITHOTRIPSY MARKET

  • 23.1 INTRODUCTION
  • 23.2 MARKET ANALYSIS AND FORECAST
  • 23.3 DRIVERS AND LIMITERS
    • 23.3.1 Market Drivers
    • 23.3.2 Market Limiters
  • 23.4 COMPETITIVE MARKET SHARE ANALYSIS

APPENDIX III: PERIPHERAL IVUS CATHETER MARKET

  • 24.1 INTRODUCTION
  • 24.2 MARKET ANALYSIS AND FORECAST
  • 24.3 DRIVERS AND LIMITERS
    • 24.3.1 Market Drivers
    • 24.3.2 Market Limiters
  • 24.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS